Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Broadly HIV-1 Neutralizing Antibodies (bNAb) in HIV-infected Patients in Mbeya, Tanzania.

NCT03334552 is registered in ClinicalTrials.gov with Michael Hoelscher as lead sponsor.

NCT NCT03334552
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03334552 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Broadly HIV-1 Neutralizing Antibodies (bNAb) in HIV-infected Patients in Mbeya, Tanzania.
Lead sponsor
Michael Hoelscher
Phase
Observational
Overall status
Unknown status
Start date
October 15, 2017
Completion date
August 31, 2024
Enrollment
500 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv/aids